Medicine News and Research

RSS

First Edition: May 2, 2013

Today's headlines include reports about a new study detailing how expanded Medicaid access impacts beneficiaries' utilization of health care services and their overall physical health.

2 May 2013

AcelRx Pharmaceuticals reports clinical results of Sufentanil NanoTab PCA System for acute pain treatment

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.

2 May 2013

Surefire Infusion System to be used for obesity treatment

Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.

2 May 2013

Discovery opens new opportunities for future medicines to treat obesity

The body's brown fat cells play a key role in the development of obesity and diabetes. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have now discovered that we humans have two different kinds of brown fat cells and not one kind as previously thought.

2 May 2013

PLOS 'Q&A' blog post highlights PLOS Medicine series

In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."

2 May 2013

PEPFAR reauthorization 'rests with Congress,' OGAC official says

Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.

2 May 2013

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Breast cancer brain metastases present a challenge to clinicians because there are few systemic therapies capable of crossing the blood-brain barrier to control the disease.

2 May 2013

New study examines injuries to children related to amusement rides

A new study by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital examined injuries to children related to amusement rides, which included rides at amusement parks (fixed-site rides), rides at fairs and festivals (mobile rides) and rides found at local malls, stores, restaurants or arcades (mall rides).

2 May 2013

Researchers awarded grant to reduce higher rates of stroke among underserved populations

UCLA researchers and their partners across Los Angeles County have been awarded an $11 million grant to fund research on community-based interventions to reduce the higher rates of stroke and death from stroke among disadvantaged Hispanics, African Americans and Asian-Americans.

2 May 2013

PLOS' ASAP Program recognizes pioneers who have used open access research to benefit society

PLOS, the Public Library of Science, today is launching the Accelerating Science Award Program that recognizes the use of scientific research, published through Open Access, which has led to innovations in any field that benefit society. Major sponsors include the Wellcome Trust and Google.

2 May 2013

New study suggests that rural communities need different CPR recommendations

Hands-only CPR (CPR without mouth-to-mouth resuscitation), may not be the best method for rural or remote areas or for anyone who has to wait more than a few minutes for an ambulance, a new study suggests.

2 May 2013

Vanderbilt University launches Health App Challenge contest

Vanderbilt University announced today a $20,000 worldwide contest called the Health App Challenge, aimed to transform patient clinical summaries into easy to understand personalized health information.

2 May 2013

Higher vitamin D levels confer no additional benefit

In recent years, healthy people have been bombarded by stories in the media and on health websites warning about the dangers of too-low vitamin D levels, and urging high doses of supplements to protect against everything from hypertension to hardening of the arteries to diabetes.

2 May 2013

Blog examines drug donation programs, Big Pharma's role in public health agenda

"Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signaled a more collaborative approach from industry with the likes of GlaxoSmithKline, Sanofi, Johnson & Johnson and Merck all performing well in the 2012 Access to Medicine Initiative," Adam Robert Green, senior reporter with the Financial Times' "This is Africa," writes in the Royal African Society's "African Arguments" blog.

2 May 2013

New online resource provides practical guidance on caring for patients with dysphagia

Healthcare professionals caring for patients with dysphagia (swallowing difficulties) now have access to a new and comprehensive online resource called 'Medicines Optimisation in Patients with Dysphagia'.

2 May 2013

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population.

2 May 2013

Medicine News and Research

First Edition: May 2, 2013

AcelRx Pharmaceuticals reports clinical results of Sufentanil NanoTab PCA System for acute pain treatment

Surefire Infusion System to be used for obesity treatment

Discovery opens new opportunities for future medicines to treat obesity

PLOS 'Q&A' blog post highlights PLOS Medicine series

PEPFAR reauthorization 'rests with Congress,' OGAC official says

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

New study examines injuries to children related to amusement rides

Researchers awarded grant to reduce higher rates of stroke among underserved populations

PLOS' ASAP Program recognizes pioneers who have used open access research to benefit society

New study suggests that rural communities need different CPR recommendations

Vanderbilt University launches Health App Challenge contest

Higher vitamin D levels confer no additional benefit

Blog examines drug donation programs, Big Pharma's role in public health agenda

New online resource provides practical guidance on caring for patients with dysphagia

Mayo Clinic researchers identify 27 genes that respond differently to rubella vaccine

Genomics-based testing could change recommended course of treatment for endometrial cancer

Some American ob/gyn residency programs fail to offer formal training in menopause medicine

Research findings pave the way for developing better treatments for AML

Findings set the stage for identifying potential new drug targets, treatment strategies for AML

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News